Longeveron LLC (LGVN) Stock Analysis

Longeveron LLC (LGVN) is a publicly traded company in the HEALTHCARE sector. It trades at $0.76, carries a market capitalization of $24.33M. This page summarizes the public market data, fundamentals, and frequently asked questions for LGVN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.76
• Market Cap: $24.33M
• EPS: $-1.14
• 52-Week High: $1.80
• 52-Week Low: $0.47

Market Sentiment

Longeveron LLC currently has a Neutral sentiment score of -0.15.

About Longeveron LLC

Longeveron LLC (LGVN) is an innovative clinical-stage biotechnology company headquartered in Miami, Florida, dedicated to developing groundbreaking cell therapies for life-threatening and age-related conditions. The company specializes in harnessing the potential of mesenchymal stem cells to address significant health issues such as cognitive decline and cardiac frailty. With a strong focus on scientific excellence and adherence to regulatory standards, Longeveron is committed to transforming...

GNG Research Analysis

GNG Research scores Longeveron LLC (LGVN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LGVN.

Frequently Asked Questions

Does LGVN pay dividends?

Longeveron LLC (LGVN) does not currently pay a regular dividend.

What is LGVN's market cap?

Longeveron LLC (LGVN) has a market capitalization of $24.33M with a current stock price of $0.76.